ProofPilot Acquires Lokavant

September 20, 2025

ProofPilot has acquired Lokavant to integrate Lokavant’s predictive clinical-trial analytics into ProofPilot’s end-to-end clinical experience platform. The deal combines ProofPilot’s trial execution capabilities with Lokavant’s real-time and historical data-driven forecasting to improve study feasibility, recruitment, oversight, and overall trial performance.

Buyers
ProofPilot
Targets
Lokavant
Location
New York, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.